GLENMARK
Invest with MTF
Invest Now
Invest in Glenmark Pharmaceuticals with 3.42X leverage
Performance
- Low
- ₹1,951
- High
- ₹2,028
- 52 Week Low
- ₹1,276
- 52 Week High
- ₹2,285
- Open Price₹2,028
- Previous Close₹2,018
- Volume831,792
- 50 DMA₹1,980.33
- 100 DMA₹1,939.56
- 200 DMA₹1,840.15
Investment Returns
- Over 1 Month + 1.68%
- Over 3 Month + 3.55%
- Over 6 Month -7.93%
- Over 1 Year + 30.26%
Smart Investing Starts Here Start SIP with Glenmark Pharmaceuticals for Steady Growth!
Glenmark Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 56.1
- PEG Ratio
- 0.3
- Market Cap Cr
- 56,672
- P/B Ratio
- 5.9
- Average True Range
- 49.49
- EPS
- 89.11
- Dividend Yield
- 0.2
- MACD Signal
- 30.14
- RSI
- 49.99
- MFI
- 59.38
Glenmark Pharmaceuticals Financials
Glenmark Pharmaceuticals Technicals
EMA & SMA
Current Price
₹2,008.20
-9.3
(-0.46%)
- Bearish Moving Average 8
- Bullish Moving Average 8
- 20 Day
- ₹2,020.65
- 50 Day
- ₹1,980.33
- 100 Day
- ₹1,939.56
- 200 Day
- ₹1,840.15
Resistance and Support
1995.77
- R3 2,117.33
- R2 2,072.67
- R1 2,040.43
- S1 1,963.53
- S2 1,918.87
- S3 1,886.63
Glenmark Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Glenmark Pharmaceuticals F&O
About Glenmark Pharmaceuticals
- NSE Symbol
- GLENMARK
- BSE Symbol
- 532296
- Chairman & Managing Director
- Mr. Glenn Saldanha
- ISIN
- INE935A01035
Similar Stocks to Glenmark Pharmaceuticals
Glenmark Pharmaceuticals FAQs
Glenmark Pharmaceuticals share price is ₹2,008 As on 13 January, 2026 | 21:33
The Market Cap of Glenmark Pharmaceuticals is ₹56671.6 Cr As on 13 January, 2026 | 21:33
The P/E ratio of Glenmark Pharmaceuticals is 56.1 As on 13 January, 2026 | 21:33
The PB ratio of Glenmark Pharmaceuticals is 5.9 As on 13 January, 2026 | 21:33
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.